Did you know?

Find real-time VRNA - Verona Pharma PLC stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast The 6 analysts offering 12-month price forecasts for CytomX Therapeutics Inc have a median target of 2.13, with a high estimate of 3.50 and a low estimate of 2.00. Find the latest eFFECTOR Therapeutics, Inc. (EFTR) stock quote, history, news and other vital information to help you with your stock trading and investing.Find out why ACRX stock is a Hold. AcelRx Pharmaceuticals raised capital in December 2022, ... Management outlook to 2023 provided at the March 30, 2023 Earnings Call for fiscal 2022.Iterum Therapeutics plc (NASDAQ:ITRM) released its quarterly earnings results on Friday, November, 12th. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $1.80 by $1.50. During the same period last year, the company earned ($5.10) EPS. View the latest news, buy/sell ratings, SEC filings and insider transactions ...Find real-time ITRM - Iterum Therapeutics PLC stock quotes, company profile, news and forecasts from CNN Business. ACRX is currently rated as a Sucker Stock | Stockopedia. Login Get Started. ... Is there a AcelRx Pharmaceuticals share price forecast for 2023? The analyst consensus target price for shares in AcelRx Pharmaceuticals is $4.12. That is …Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 225.00, with a high estimate of 225.00 and a low estimate of 225.00. The ...ACRX has an Altman Z-Score of -27.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for AcelRx Pharmaceuticals, Inc. (ACRX) stock, including valuation metrics, financial numbers, share information and more.The AcelRx Pharmaceuticals stock price gained 3.66% on the last trading day (Wednesday, 15th Nov 2023), rising from $0.464 to $0.481. During the last trading day the stock fluctuated 11.04% from a day low at $0.450 to a day high of $0.500. The price has fallen in 6 of the last 10 days and is down by -9.09% for this period.ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now.3.91%. $84.57M. SRNEQ | Complete Sorrento Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest AcelRx Pharmaceuticals, Inc. ACRX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating ...Vince Angotti. AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.AcelRx Pharmaceuticals (ACRX) came out with a quarterly loss oFind real-time GNPX - Genprex Inc stock Analyst Forecast. According to 3 analysts, the average rating for SLNO stock is "Strong Buy." The 12-month stock price forecast is $29.67, which is an increase of 3.16% from the latest price. Find real-time SPRO - Spero Therapeutics Inc stock quotes, comp The forecasts range from a low of $4.25 to a high of $5.00. The average price target represents an increase of 571.01% from the last closing price of $0.69. …Buy or Hold candidate since Nov 24, 2023 Loss -0.71% PDF. The AcelRx Pharmaceuticals stock price fell by -4.70% on the last day (Wednesday, 29th Nov … View the latest Ford Motor Co. (F) stock price, news, historica

Find real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.1.49%. $75.35M. Cara Therapeutics Inc. 13.45%. $73M. ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.REDMOND, Wash. — January 24, 2023 — Microsoft Corp. today announced the following results for the quarter ended December 31, 2022, as compared to the corresponding period of last fiscal year: Revenue was $52.7 billion and increased 2%. Operating income was $20.4 billion GAAP and $21.6 billion non-GAAP, and decreased …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 4.63, with a high estimate of 5.00 and a low estimate of 4.25. The median estimate represents a …10% most volatile stocks in US Market. 15.5%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: APLD is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week. Volatility Over Time: APLD's weekly volatility has decreased from 18% to 12% over the past year, but is still higher than 75% of US ...

The stock boasts 4 recent buy ratings vs just 1 hold rating. This is with an $7.75 average price target, suggesting shares could surge 113%. Get the ACRX Stock Research Report.1 January 2022 / pennystocks.com / 4 min read Top Penny Stocks To Buy According To Analysts & Targets Up To 615%…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. May 15, 2023 · Earnings announcement* for ACRX: May 1. Possible cause: Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Vi.